HIV and Rare Opportunistic Infections: Immune Mechanisms and Prevention

Why HIV Increases Rare Disease Susceptibility

HIV depletes CD4+ T‑helper cells, crippling cell‑mediated immunity and humoral coordination. As CD4 count falls (<200 cells/µL), opportunistic infections (OIs) emerge.

Key Factors

  1. Opportunistic infections: Pneumocystis jirovecii pneumonia (PCP), cytomegalovirus (CMV), cryptococcal meningitis, toxoplasmosis, Mycobacterium avium complex (MAC), Kaposi sarcoma (HHV‑8).
  2. Impaired antibody production: Reduced response to new antigens and vaccines.
  3. High viral load: Direct immune activation and exhaustion.
  4. Co‑infections: HBV, HCV, STIs accelerate immune decline.
  5. Chronic immune activation: Persistent inflammation drives non‑AIDS comorbidities (CVD, neurocognitive decline).

Prevention and Management

  • Early ART initiation (treat all regardless of CD4).
  • OI prophylaxis per CD4 thresholds (e.g., TMP‑SMX for PCP <200).
  • Vaccinations (inactivated preferred).
  • Regular monitoring (CD4, viral load, renal/hepatic function).
  • Screening/treatment for co‑infections.

HIV & AIDS - Related Articles